STOCK TITAN

Curaleaf to Report Third Quarter 2023 Financial and Operational Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Curaleaf Holdings, Inc. to report Q3 2023 financial results on November 9, 2023
Positive
  • Curaleaf Holdings, Inc. will report its financial and operating results for Q3 2023 after market close on November 9, 2023.
Negative
  • None.

NEW YORK, Oct. 10, 2023 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the third quarter ended September 30, 2023 after market close on November 9, 2023.

Management will host a conference call and audio webcast that afternoon at 5:00 p.m. ET consisting of prepared remarks followed by a question-and-answer session related to the Company's operational and financial highlights.

Event:


Curaleaf Third Quarter 2023 Financial Results Conference Call

Date:


Thursday, November 9, 2023

Time:


5:00 p.m. ET

Live Call:


+1-844-512-2926 (U.S.), +1-416-639-5883 (Canada) or +1-412-317-6300 (International)

Passcode:


5965371

Webcast:


https://ir.curaleaf.com/events


For interested individuals unable to join the conference call, a dial-in replay of the call will be available until November 16, 2023, and can be accessed by dialing +1-877-344-7529 (U.S.), +1-855-669-9658 (Canada) or +1-412-317-0088 (International) and entering replay pin number: 6181764

About Curaleaf Holdings

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 18 states with 150 dispensaries and employs nearly 5,500 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Curaleaf IR Twitter Account: https://twitter.com/Curaleaf_IR    

Investor Relations Website: https://ir.curaleaf.com/

Investor Contact: 
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer 
IR@curaleaf.com

Media Contact: 
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
media@curaleaf.com 

 

Cision View original content:https://www.prnewswire.com/news-releases/curaleaf-to-report-third-quarter-2023-financial-and-operational-results-301952796.html

SOURCE Curaleaf Holdings, Inc.

FAQ

When will Curaleaf Holdings, Inc. report its Q3 2023 financial results?

Curaleaf Holdings, Inc. will report its Q3 2023 financial results on November 9, 2023.

What time is the conference call for Curaleaf's Q3 2023 financial results?

The conference call for Curaleaf's Q3 2023 financial results will take place at 5:00 p.m. ET on November 9, 2023.

How can I access the webcast for Curaleaf's Q3 2023 financial results?

You can access the webcast for Curaleaf's Q3 2023 financial results at https://ir.curaleaf.com/events.

Is there a replay available for the conference call?

Yes, a dial-in replay of the conference call will be available until November 16, 2023. You can access it by dialing the respective numbers and entering the replay pin number.

CURALEAF HLDGS INC

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

1.67B
411.16M
29.87%
1.36%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
New York